+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Bifurcation Lesions Market Size, Share & Trends Analysis Report By Application (Coronary Vascular, Peripheral Vascular), By Region (North America, Asia Pacific, Europe), And Segment Forecasts, 2023 - 2030

  • PDF Icon

    Report

  • 90 Pages
  • September 2023
  • Region: Global
  • Grand View Research
  • ID: 5893308
Description Jump to:
The global bifurcation lesions market size is expected to reach USD 3.48 billion by 2030, registering a CAGR of 5.9% during the forecast period. Technological developments and supportive government initiatives for reimbursement are likely to drive the market during the forecast period.

The increasing geriatric population and unhealthy lifestyle are responsible for growth in the incidence of cardiovascular disorders. Furthermore, an increase in approval & commercialization of innovative devices and the expected entry of new devices for the treatment of bifurcation lesions in the coming years are likely to drive the market.

In addition, factors such as rising affordability, increase in demand for minimally invasive procedures, and growing medical tourism are also boosting demand for bifurcation lesions procedures across the globe. According to various studies, procedures for coronary bifurcation lesions comprise approximately 20% of total percutaneous coronary interventions.

Bifurcation Lesions Market Report Highlights

  • Increase in the commercialization of devices for bifurcation lesions and investments by industry players for R&D are the factors expected to boost the market, resulting in an anticipated CAGR of around 5.9% from 2023 to 2030
  • The coronary vascular segment accounted for the maximum share of the market in 2022 due to the presence of complex vascular network in heart, increased availability of devices, and rise in awareness regarding surgical interventions for bifurcation lesions.
  • The peripheral vascular segment is likely to witness lucrative growth in the coming years due to an increase in investments by industry players for the development of devices for peripheral application and advancements in diagnostics facilitating accurate detection of plaque.
  • Geographically, North America held the largest share of the bifurcation lesions market in 2022. It is anticipated to maintain its dominance in the coming years due to increasing demand for drug-eluting stents, commercialization of devices for bifurcation lesions, and the local presence of major market players.
  • The Asia Pacific is expected to observe the fastest growth over the next decade owing to improvement in healthcare infrastructure, medical tourism, and a rise in investments by market players in the region.
  • Some of the key players in the market are Abbott; Boston Scientific Corporation; Cardinal Health; Medtronic; Johnson & Johnson Services, Inc.; C. R. Bard, Inc.; Spectranetics; and Terumo Medical Corporation. Tryton Medical, Inc. developed the Tryton Side Branch Stent with a balloon-expandable, single-wire stent delivery system that can be deployed in the side branch artery for treatment of bifurcation lesions. The device is available in the U.S. and Europe as well as Middle East & Africa.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Application
1.1.2. Regional scope
1.1.3. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Application outlook
2.2.2. Regional outlook
2.3. Competitive Insights
Chapter 3. Bifurcation Lesions Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. Bifurcation Lesions Market Analysis Tools
3.4.1. Industry Analysis - Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape
Chapter 4. Bifurcation Lesions: Application Estimates & Trend Analysis
4.1. Bifurcation Lesions Market: Key Takeaways
4.2. Bifurcation Lesions Market: Movement & Market Share Analysis, 2022 & 2030
4.3. Peripheral Vascular
4.3.1. Peripheral vascular market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. Coronary Vascular
4.4.1. Coronary vascular market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Bifurcation Lesions Market: Regional Estimates & Trend Analysis
5.1. Regional Outlook
5.2. Bifurcation Lesions Market by Region: Key Marketplace Takeaways
5.3. North America
5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.3.2. U.S.
5.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.3.3. Canada
5.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.4. Europe
5.4.1. UK
5.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.4.2. Germany
5.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.4.3. France
5.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.4.4. Italy
5.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.4.5. Spain
5.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.4.6. Sweden
5.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.4.7. Norway
5.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.4.8. Denmark
5.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.5. Asia Pacific
5.5.1. Japan
5.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.5.2. China
5.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.5.3. India
5.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.5.4. Australia
5.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.5.5. Thailand
5.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.5.6. South Korea
5.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.6. Latin America
5.6.1. Brazil
5.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.6.2. Mexico
5.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.6.3. Argentina
5.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.7. MEA
5.7.1. Saudi Arabia
5.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.7.2. South Africa
5.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.7.3. UAE
5.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.7.4. Kuwait
5.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Chapter 6. Competitive Landscape
6.1. Recent Developments & Impact Analysis, By Key Market Participants
6.2. Market Participant Categorization
6.2.1. Boston Scientific Corporation
6.2.1.1. Company overview
6.2.1.2. Financial performance
6.2.1.3. Product benchmarking
6.2.1.4. Strategic initiatives
6.2.2. Abbott
6.2.2.1. Company overview
6.2.2.2. Financial performance
6.2.2.3. Product benchmarking
6.2.2.4. Strategic initiatives
6.2.3. Cardinal Health
6.2.3.1. Company overview
6.2.3.2. Financial performance
6.2.3.3. Product benchmarking
6.2.3.4. Strategic initiatives
6.2.4. Medtronic
6.2.4.1. Company overview
6.2.4.2. Financial performance
6.2.4.3. Product benchmarking
6.2.4.4. Strategic initiatives
6.2.5. C. R. Bard, Inc.
6.2.5.1. Company overview
6.2.5.2. Financial performance
6.2.5.3. Product benchmarking
6.2.5.4. Strategic initiatives
6.2.6. Johnson and Johnson Services, Inc.
6.2.6.1. Company overview
6.2.6.2. Financial performance
6.2.6.3. Product benchmarking
6.2.6.4. Strategic initiatives
6.2.7. Spectranetics
6.2.7.1. Company overview
6.2.7.2. Financial performance
6.2.7.3. Product benchmarking
6.2.7.4. Strategic initiatives
6.2.8. Terumo Medical Corporation
6.2.8.1. Company overview
6.2.8.2. Financial performance
6.2.8.3. Product benchmarking
6.2.8.4. Strategic initiatives
6.2.9. Tryton Medical Inc.
6.2.9.1. Company overview
6.2.9.2. Financial performance
6.2.9.3. Product benchmarking
6.2.9.4. Strategic initiatives
List of Tables
1. List of Abbreviations
2. North America bifurcation lesions market, by application, 2018 - 2030 (USD Million)
3. North America bifurcation lesions market, by region, 2018 - 2030 (USD Million)
4. U.S. bifurcation lesions market, by application, 2018 - 2030 (USD Million)
5. Canada bifurcation lesions market, by application, 2018 - 2030 (USD Million)
6. Europe bifurcation lesions market, by application, 2018 - 2030 (USD Million)
7. Europe bifurcation lesions market, by region, 2018 - 2030 (USD Million)
8. Germany bifurcation lesions market, by application, 2018 - 2030 (USD Million)
9. UK bifurcation lesions market, by application, 2018 - 2030 (USD Million)
10. France bifurcation lesions market, by application, 2018 - 2030 (USD Million)
11. Italy bifurcation lesions market, by application, 2018 - 2030 (USD Million)
12. Spain bifurcation lesions market, by application, 2018 - 2030 (USD Million)
13. Sweden bifurcation lesions market, by application, 2018 - 2030 (USD Million)
14. Norway bifurcation lesions market, by application, 2018 - 2030 (USD Million)
15. Denmark bifurcation lesions market, by application, 2018 - 2030 (USD Million)
16. Asia Pacific bifurcation lesions market, by application, 2018 - 2030 (USD Million)
17. Asia Pacific bifurcation lesions market, by region, 2018 - 2030 (USD Million)
18. China bifurcation lesions market, by application, 2018 - 2030 (USD Million)
19. Japan bifurcation lesions market, by application, 2018 - 2030 (USD Million)
20. India bifurcation lesions market, by application, 2018 - 2030 (USD Million)
21. Australia bifurcation lesions market, by application, 2018 - 2030 (USD Million)
22. Thailand bifurcation lesions market, by application, 2018 - 2030 (USD Million)
23. South Korea bifurcation lesions market, by application, 2018 - 2030 (USD Million)
24. Latin America bifurcation lesions market, by application, 2018 - 2030 (USD Million)
25. Latin America bifurcation lesions market, by region, 2018 - 2030 (USD Million)
26. Brazil bifurcation lesions market, by application, 2018 - 2030 (USD Million)
27. Mexico bifurcation lesions market, by application, 2018 - 2030 (USD Million)
28. Argentina bifurcation lesions market, by application, 2018 - 2030 (USD Million)
29. Middle East and Africa bifurcation lesions market, by application, 2018 - 2030 (USD Million)
30. Middle East and Africa bifurcation lesions market, by region, 2018 - 2030 (USD Million)
31. South Africa bifurcation lesions market, by application, 2018 - 2030 (USD Million)
32. Saudi Arabia bifurcation lesions market, by application, 2018 - 2030 (USD Million)
33. UAE bifurcation lesions market, by application, 2018 - 2030 (USD Million)
34. Kuwait bifurcation lesions market, by application, 2018 - 2030 (USD Million)
List of Figures
1. Market research process
2. Data triangulation techniques
3. Primary research pattern
4. Market research approaches
5. Value-chain-based sizing & forecasting
6. QFD modeling for market share assessment
7. Market formulation & validation
8. Bifurcation lesions: Market outlook
9. Bifurcation lesions: Competitive insights
10. Parent market outlook
11. Related/ancillary market outlook
12. Penetration and growth prospect mapping
13. Industry value chain analysis
14. Bifurcation lesions market driver impact
15. Bifurcation lesions market restraint impact
16. Bifurcation lesions market strategic initiatives analysis
17. Bifurcation lesions market: Application movement analysis
18. Bifurcation lesions market: Application outlook and key takeaways
19. Peripheral vascular market estimates and forecasts, 2018 - 2030 (USD Million)
20. Coronary vascular market estimates and forecasts, 2018 - 2030 (USD Million)
21. Global bifurcation lesions market: Regional movement analysis
22. Global bifurcation lesions market: Regional outlook and key takeaways
23. North America market estimates and forecasts, 2018 - 2030 (USD Million)
24. U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
25. Canada market estimates and forecasts, 2018 - 2030 (USD Million)
26. Europe market estimates and forecasts, 2018 - 2030 (USD Million)
27. UK market estimates and forecasts, 2018 - 2030 (USD Million)
28. Germany market estimates and forecasts, 2018 - 2030 (USD Million)
29. France market estimates and forecasts, 2018 - 2030 (USD Million)
30. Italy market estimates and forecasts, 2018 - 2030 (USD Million)
31. Spain market estimates and forecasts, 2018 - 2030 (USD Million)
32. Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
33. Norway market estimates and forecasts, 2018 - 2030 (USD Million)
34. Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
35. Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
36. Japan market estimates and forecasts, 2018 - 2030 (USD Million)
37. China market estimates and forecasts, 2018 - 2030 (USD Million)
38. India market estimates and forecasts, 2018 - 2030 (USD Million)
39. Australia market estimates and forecasts, 2018 - 2030 (USD Million)
40. Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
41. South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
42. Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
43. Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
44. Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
45. Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
46. Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Million)
47. Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
48. South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
49. UAE market estimates and forecasts, 2018 - 2030 (USD Million)
50. Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)

Companies Mentioned

  • Boston Scientific Corporation
  • Abbott
  • Cardinal Health
  • Medtronic
  • C. R. Bard, Inc.
  • Johnson and Johnson Services, Inc.
  • Spectranetics
  • Terumo Medical Corporation
  • Tryton Medical Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages90
PublishedSeptember 2023
Forecast Period2022 - 2030
Estimated Market Value ( USD ) in 2022 $ 2.2 Billion
Forecasted Market Value ( USD ) by 2030 $ 3.48 Billion
Compound Annual Growth Rate5.9%
Regions CoveredGlobal
No. of Companies Mentioned9

Related Topics

Related Reports

Bifurcation Lesions Market by Type, Application - Global Forecast 2025-2030 - Product Image

Bifurcation Lesions Market by Type, Application - Global Forecast 2025-2030

  • Report
  • 190 Pages
  • Global
From
Bifurcation Lesions Global Market Report 2024 - Product Image

Bifurcation Lesions Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Bifurcation Lesions - Global Strategic Business Report - Product Image

Bifurcation Lesions - Global Strategic Business Report

  • Report
  • 93 Pages
  • Global
From
Bifurcation Lesions Market Report by Types, Application, and Region 2024-2032 - Product Image

Bifurcation Lesions Market Report by Types, Application, and Region 2024-2032

  • Report
  • 135 Pages
  • Global
From
Bifurcation Lesions Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F - Product Image

Bifurcation Lesions Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

  • Report
  • 184 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.